Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease | Zendy

Gunnar Tepe | Zendy; John R. Laird | Zendy; Peter A. Schneider | Zendy; Marianne Brodmann | Zendy; Prakash Krishnan | Zendy; Antonio Micari | Zendy; Christopher Metzger | Zendy; Dierk Scheinert | Zendy; Thomas Zeller | Zendy; David J. Cohen | Zendy; David B. Snead | Zendy; Beaux Alexander | Zendy; Mario Landini | Zendy; Michael R. Jaff | Zendy

Open Access

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

Author(s) -

Gunnar Tepe,

John R. Laird,

Peter A. Schneider,

Marianne Brodmann,

Prakash Krishnan,

Antonio Micari,

Christopher Metzger,

Dierk Scheinert,

Thomas Zeller,

David J. Cohen,

David B. Snead,

Beaux Alexander,

Mario Landini,

Michael R. Jaff

Publication year - 2014

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.114.011004

Subject(s) - medicine , popliteal artery , percutaneous , superficial femoral artery , angioplasty , femoral artery , peripheral , surgery , balloon , arterial disease , vascular disease , radiology

Drug-coated balloons (DCBs) have shown promise in improving the outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated balloon with percutaneous transluminal angioplasty (PTA) for the treatment of symptomatic superficial femoral and popliteal artery disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research